These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 13202445)

  • 1. [Biology of carcinoma. II. Cold resistance of the cancer cell].
    HOMANN W
    Krebsarzt; 1954 Aug; 9(4):223-30. PubMed ID: 13202445
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular analysis of anoikis resistance in oral cavity squamous cell carcinoma.
    Kupferman ME; Patel V; Sriuranpong V; Amornphimoltham P; Jasser SA; Mandal M; Zhou G; Wang J; Coombes K; Multani A; Pathak S; Silvio Gutkind J; Myers JN
    Oral Oncol; 2007 May; 43(5):440-54. PubMed ID: 16978912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mouse Tumor Biology Database: integrated access to mouse cancer biology data.
    Krupke D; Näf D; Vincent M; Allio T; Mikaelian I; Sundberg J; Bult C; Eppig J
    Exp Lung Res; 2005 Mar; 31(2):259-70. PubMed ID: 15824024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cells and cancer tissue. III. Immunogenetic aspects. Cancer grafts].
    AMIEL JL; MATHE G
    Rev Prat; 1963 Apr; 13():1057-64. PubMed ID: 14012588
    [No Abstract]   [Full Text] [Related]  

  • 5. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval.
    Goffin J; Baral S; Tu D; Nomikos D; Seymour L
    Clin Cancer Res; 2005 Aug; 11(16):5928-34. PubMed ID: 16115935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer biology.
    Curr Opin Oncol; 1993 Jan; 5(1):193-248. PubMed ID: 8427889
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.
    Onn A; Isobe T; Itasaka S; Wu W; O'Reilly MS; Ki Hong W; Fidler IJ; Herbst RS
    Clin Cancer Res; 2003 Nov; 9(15):5532-9. PubMed ID: 14654533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human NSCLC cell line with innate etoposide-resistance mediated by cytoplasmic localization of topoisomerase II alpha.
    de Lucio B; Manuel V; Barrera-Rodríguez R
    Cancer Sci; 2005 Nov; 96(11):774-83. PubMed ID: 16271071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANTHRAMINE CARCINOGENESIS IN THE SKIN OF RATS. II. THE PILOSEBACEOUS APPARATUS.
    DOBSON RL
    J Natl Cancer Inst; 1963 Oct; 31():861-71. PubMed ID: 14069832
    [No Abstract]   [Full Text] [Related]  

  • 12. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines.
    Patlolla JM; Swamy MV; Raju J; Rao CV
    Oncol Rep; 2004 May; 11(5):957-63. PubMed ID: 15069532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of testicular cancer. I. Behavior after transplantation.
    PIERCE B; VERNEY EL; DIXON FJ
    Cancer Res; 1957 Feb; 17(2):134-8. PubMed ID: 13413850
    [No Abstract]   [Full Text] [Related]  

  • 14. Further observations on biology of the BS-tumour. II. Immunobiological properties of the BS-tumour.
    POSPISIL L; SVEJDA J
    Neoplasma; 1957; 4(4):398-401. PubMed ID: 13504388
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to the tubulin-binding agents in renal cell carcinoma: no mutations in the class I beta-tubulin gene but changes in tubulin isotype protein expression.
    Ferguson RE; Taylor C; Stanley A; Butler E; Joyce A; Harnden P; Patel PM; Selby PJ; Banks RE
    Clin Cancer Res; 2005 May; 11(9):3439-45. PubMed ID: 15867246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
    O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
    Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling therapy resistance in genetically engineered mouse cancer models.
    Rottenberg S; Jonkers J
    Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel cell-based assay to evaluate the malignant potential of cancer in vitro.
    Hirakawa C; Tanaka K; Takaya Y; Nakagawa S; Kataoka Y; Tagawa Y; Niwa M
    Anticancer Res; 2009 Jul; 29(7):2541-5. PubMed ID: 19596926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
    Voskoglou-Nomikos T; Pater JL; Seymour L
    Clin Cancer Res; 2003 Sep; 9(11):4227-39. PubMed ID: 14519650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.